Andre Lieber
Medical Genetics
Adjunct Professor

Faculty Information


In 1994, I joined Mark Kay’s newly established Gene Therapy group in Seattle as a postdoctoral fellow of the Germany Academic Exchange Service (DAAD) and German Research Society (DFG). In 1998, I became an independent investigator at the level of Research Assistant Professor in the Division of Medical Genetics. In 2010, I was promoted to full professor, in 2015 “with tenure”. 

In 2010, I co-founded a start-up company, through which we have raised money for two clinical trials with cancer co-therapeutics that were developed in my laboratory.

From 2013 to 2016, I was the Secretary of the American Society of Stem Cell and Gene Therapy, where I was largely responsible for the abstract review process and the poster and oral presentation program. I regularly serve on NIH study sections and I am on the editorial board of 4 gene therapy-related journals.  I am dedicated to motivating students for a medical research career. During the past ten years, I have supervised 17 post-docs, 6 graduate students, 23 undergraduate students, and 5 visiting scientists.

Pronouns: He/Him/His

Education & Training: 
Second Medical Institute
Moscow, Russia
Humboldt University
Berlin, Germany
Elected Member of the American Society of Clinical Investigation